Oregon Makes It Illegal to Block Dying Patients From Their Medical Cannabis. Other States Are Moving the Same Way.

There is a particular cruelty in telling someone who is dying that they can’t have the medicine that helps them through it.

For years, that was the reality for Oregon’s medical cannabis cardholders who entered residential hospice or palliative care. State law recognized their right to use cannabis. Hospice facilities didn’t have to. The license said yes. The facility said no. The patient had no recourse.

That changed Thursday. Gov. Tina Kotek signed HB 4142 into law, making Oregon the third state in 2026 to require eligible residential healthcare facilities to accommodate medical cannabis use by licensed patients. The law takes effect January 1, 2027.

What This Bill Actually Does

HB 4142 applies specifically to residential facilities providing hospice or palliative care — meaning end-of-life or comfort-focused treatment. Under the new law, those facilities must permit qualified patients who hold a valid Oregon medical cannabis card to consume cannabis products on-site.

It also imposes a training requirement: facility employees must complete cannabis-specific education before providing care to eligible patients. The intent is to prevent a common workaround — staff refusing to assist or flagging cannabis use as a safety concern because they don’t understand the products involved.

What the law does not do: it doesn’t require facilities to purchase, store, or dispense cannabis. Patients or their designated caregivers are responsible for obtaining and supplying it. The facility’s obligation is accommodation — not provision.

It also doesn’t apply to acute care hospitals or standard residential facilities. The statute is targeted specifically at end-of-life care settings.

Who It Affects

Oregon has approximately 70,000 active medical cannabis cardholders. A fraction of them — but a growing one — will need hospice or palliative care in the coming years.

For those patients, the stakes are high and very specific. Hospice is not a treatment designed to cure. It is a system designed to manage pain, reduce suffering, and help people die on their own terms. Cannabis has well-documented applications in that context: it reduces nausea from other medications, manages pain that opioids sometimes don’t reach, and in some patients substantially reduces anxiety in the final weeks of life.

Before HB 4142, an Oregon patient with a legal medical cannabis card could be told, upon admission to a residential hospice facility, that their medicine wasn’t welcome there. Their choice became: give up the cannabis, or don’t enter the facility. In practice, many patients can’t choose. Their condition requires the facility’s care. The cannabis was the thing they gave up.

The Direction

This is not Oregon doing something novel. It is Oregon catching up with a trend that has accelerated faster than most people realize.

Colorado passed a similar law earlier this year, allowing terminally ill patients to access cannabis in eligible hospitals. Virginia followed, with legislation that goes further — specifying that hospital staff may store, dispense, and administer cannabis oil when a patient has valid certification.

Similar bills are pending in Connecticut, Hawaii, Louisiana, and Pennsylvania. The NORML Act Center lists multiple additional states monitoring the issue.

The legislative logic is consistent across all of these states: medical cannabis is legal, these patients are licensed to use it, and there is no legitimate public safety reason to bar it at a facility where the stated mission is comfort care. The argument against is almost always administrative — facilities citing staff training gaps, federal drug-free workplace funding rules, or liability exposure — rather than clinical.

That’s also why the training requirement in Oregon’s law matters. It addresses the most common administrative objection head-on.

The federal angle is real but not determinative here. Hospice facilities that receive Medicare and Medicaid reimbursement operate under federal oversight, and cannabis remains a Schedule I controlled substance federally. But states have increasingly found that a carefully scoped state law — limited to state-licensed patients, requiring the facility to accommodate rather than dispense, and excluding federal enforcement triggers — can coexist with federal funding rules. Oregon’s bill follows that model closely.

What Happens Next

HB 4142 has a firm effective date: January 1, 2027. Facilities now have approximately eight and a half months to develop policy, arrange staff training, and operationalize the new requirement.

The Oregon Health Authority will likely issue guidance on implementation — what “accommodation” means in practice, what the training must cover, and how facilities document compliance. Advocates will be watching how quickly that guidance comes and how clearly it protects patients.

Nationally, the bills pending in Connecticut, Hawaii, Louisiana, and Pennsylvania are in various stages of committee consideration. The Oregon signing is expected to give them a small boost — another blue-state governor on record as willing to sign this kind of legislation.

Who’s Behind This

Gov. Tina Kotek (D-OR) signed the bill without significant public statement. Her office has been broadly supportive of medical cannabis access initiatives. Kotek’s signature is consistent with her record on health equity issues.

The bill’s sponsors in the Oregon Legislature — who drove HB 4142 through both chambers — were motivated primarily by constituent pressure from medical cannabis patient advocates and hospice care workers who described watching patients go without their medication during their final weeks of life. No significant organized opposition emerged.

The hospice and palliative care industry in Oregon did not publicly oppose the bill but has raised implementation questions — particularly around staff training timelines and liability protections for employees in states where federal drug law still nominally applies. These concerns are legitimate and are likely to shape how OHA writes the implementation guidance.

NORML, which tracked and supported the bill, notes that similar laws in Colorado and Virginia were signed without significant industry opposition once the training requirements were understood. The pattern suggests that the hospice sector’s objections are operational rather than principled.

The Bottom Line

Oregon’s new law does one thing cleanly: it prevents residential hospice and palliative care facilities from taking away a dying patient’s legal medicine. It doesn’t require facilities to procure or handle cannabis. It requires them to stop saying no.

That’s a narrow but important protection — and it arrives as a growing number of states reach the same conclusion through their own legislative processes. By the time HB 4142 takes effect on January 1, 2027, it may be far from the most recent state to have crossed this line.